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Abstract 
The detection of specific proteins, as biomarkers of disease, health status, environmental monitoring, 
food quality, control of fermenters and civil defence purposes means that biosensors for these targets 
will become increasing more important. Among the technologies used for building specific 
recognition properties, molecularly imprinted polymers, molecularly imprinted polymers (MIPs) are 
attracting much attention. In this critical review we describe many of methods used for imprinting 
recognition for protein targets in polymers and their incorporation with a number of transducer 
platforms with the aim of identifying the most promising approaches for the preparation of MIP-based 
protein sensors. 
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1. Introduction 
The selective detection and quantification of protein targets has wide applicability to a number of 
fields, including clinical diagnostics and therapeutic monitoring, control of bioreactors and the 
detection of organisms and toxins, including bio-terror agents. While laboratory-based methods such 
as HPLC-MS and immunoassay can provide precise measurements, they are generally too slow for 
situations when a rapid response or intervention is needed. Under these circumstances a biosensor can 
provide faster analysis with a direct read-out without the need to transport samples to a laboratory. 
Biosensors in which the recognition element is a molecularly imprinted receptor, rather that a 
biomolecule, offer a number of advantages; notably greater long-term storage stability, potential re-
usability, resistance to microbial spoilage and custom synthesis of selective receptors without the need 
to inoculate laboratory animals. The literature on molecularly imprinted polymers (MIPs) for protein 
detection however contains a multitude of potential methods which is compounded by the numerous 
methods proposed for the transduction of the binding event to a useful signal. In this review we will 
present a critical assessment of the methods of protein imprinting and MIP-based biosensor 
development with the aim of identifying the most promising strategies for the creation of a sensitive 
and selective MIP-based biosensor for a protein target. 
1.1 Key requirements of a biosensor for the detection of a specific protein 
Soper et al. (2006) defined a biosensor as a:  
“..bioanalytical device incorporating a biological material or a biomimic (e.g., tissue, microorganisms, 
organelles, cell receptors, enzymes, antibodies, nucleic acids, etc.), intimately associated with or 
integrated within a physicochemical transducer or transducing microsystem, which may be optical, 
electrochemical, thermometric, piezoelectric or magnetic. The usual aim of a biosensor is to produce 
either discrete or continuous digital electronic signals, which are proportional to a single analyte or a 
related group of analytes.”1  
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The key requirements of a biosensor for detection of a protein are that it should be specific for its 
target and capable of measuring the analyte concentration over the required analytical concentration 
range. This requires that the recognition element (the “biological material or biomimic” in the above 
definition) is capable of selective binding of the target analyte with high affinity. Additionally there is 
an increasing need for biosensors to be resistant to a variety of chemical environments and tolerant to 
extremes of temperature and humidity and to resist bio-fouling. The vast majority of biosensors rely 
on biological reagents, including those of animal origin (enzymes and antibodies), to obtain the 
required specificity and selectivity for an assay. The selection of a suitable recognition element 
enables the assay to be both accurate and precise in its measurement. In nature the selectivity of these 
molecules has arisen through the evolutionary need to protect the organism or to regulate other 
processes to ensure survival. The latter role is filled by enzymes, which catalyse a huge range of 
metabolic and regulatory functions within the organism in a very specific and selective manner. These 
qualities have led to the utilisation of enzymes in devices such as the glucose biosensor.
2
  Another 
important class of bio-molecule used in sensing are the antibodies. These are typified by 
immunoglobulin G (IgG), which is the familiar Y-shaped molecule which possesses two highly 
specific and selective binding domains at the end of the arms of the “Y”. IgG was first employed as 
the recognition element by Yalow and Berson in a radio-immunoassays format,
3
 and is now widely 
employed in a range of biosensor and bioassay configurations. Whilst these bio-molecules fulfil the 
requirements of specificity, selectivity and ease of use, such as the ability to absorb or chemically 
couple to solid surfaces with little denaturation,
4
 they have limited stability to extremes of temperature 
(denaturing above ~40 ºC) and humidity as well susceptibility to damage by shear forces, such as 
those encountered in continuous monitoring situations. Recent efforts have included studies with 
antibodies and antibody fragments from camelids such as the llama
5
 or from sharks
6
 to overcome 
some of these issues. These antibodies differ from conventional IgG since they consist of only a single 
heavy chain which imparts greater temperature stability without sacrificing specificity or selectivity. 
The only drawback is that these proteins still have a tendency to unfold at higher temperature but re-
fold to their original shape when the temperature is lowered, with the consequence that the reliability 
of assays utilising these molecules will diminish at operating temperatures above around 40 ºC. It is 
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for these reasons that biomimetic materials, such as molecularly imprinted polymers (MIPs) are of 
interest, since they hold the promise of selective recognition and robustness to a range of hash 
operating conditions not tolerated by their biological counterparts. 
1.2 Molecularly imprinted polymers  
As mentioned in the previous section, the construction of many current and future diagnostic devices 
relies almost exclusively on the use of sophisticated biological receptors, such as enzymes, antibodies 
and DNA, as the chemical or biochemical recognition element.
7-9
 Due to their biological origins, these 
biomolecules may suffer from some inherent limitations when used in sensors and assays; for 
example, poor reproducibility, instability during the manufacturing process and problems associated 
with sterilisation. Synthetic receptors therefore may offer a promising alternative to antibodies and 
other biological receptors for use in biosensors.
10
  The most generic and cost-effective technique for 
preparing synthetic receptors, which combines high affinity and specificity with robustness and low 
manufacturing costs is molecular imprinting.
11
  
Molecular imprinting can be defined as the formation of specific recognition sites (with binding or 
catalytic properties) in a material through its interaction with a template, where the template directs 
the positioning and orientation of the material's structural components by a self-assembly mechanism 
(Figure 1). The material itself could be a linear sequence (in the most general sense, even DNA 
replication is a type of imprinting process), polymeric (organic MIPs and inorganic imprinted silica 
gels) or 2-dimensional surface assemblies (grafted monolayers). MIPs have a range of advantages 
when compared with natural biomolecules (Table 1). Imprinted polymers can in theory be prepared 
for any kind of substances. The best results however were obtained for molecules with molecular 
weights in the range of 200-1200 Da. 
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Figure 1: Scheme of (a) three-dimensional and (b) two-dimensional imprinting polymerisation 
(courtesy of VTT, Finland). 
 
Table 1: Comparison of natural biomolecules used in sensors and MIPs.  
Natural biomolecules MIPs 
Low stability Stable to low/high pH, pressure and temperature 
(<180 ºC) 
High price of enzymes and receptors  Inexpensive and easy to prepare 
 
Generally poor performance in non-aqueous 
media 
MIPs can work in organic solvents 
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Different natural biomolecules have their own 
operational requirements (pH, ionic strength, 
temperature, substrate etc.) 
Due to their minimal operational requirements, 
the design of MIP-based multisensors is a 
relatively easy task 
Natural receptors and enzymes exist for only a 
limited number of important analytes 
In principle, MIPs can be prepared for practically 
any compound 
Poor compatibility with micromachining 
technology and miniaturisation 
Polymers are fully compatible with 
micromachining technology 
Soluble Most MIPs are insoluble co-polymers 
 
Many hundreds of examples of successful imprinting have been demonstrated, including MIPs for 
inorganic ions, drugs, nucleic acids, proteins and even microbial cells.
12
 The resulting polymers are 
robust, inexpensive and, in many cases, possess levels of affinity and specificity suitable for industrial 
applications. The quality of the synthesised materials depends to a large degree on the type of 
template. For example, it is relatively easy to imprint rigid and stable lipophillic drug molecules with 
several polar functional groups.
13
 Other factors which affect the quality of MIPs include: monomer 
composition, solvents, polymerisation time, temperature, even the application of a magnetic field.
14
 
Imprinted polymers can be produced in bulk, in thin film format and as membranes
15
 or as a 
suspension of spherical particles with well-defined size.
16
 The high specificity and stability of MIPs 
renders them promising alternatives to enzymes, antibodies, and natural receptors for use in sensor 
technology.
17,18
 The growing interest in MIPs can be illustrated by the fact that almost 10% of all 
papers published on the subject of “biosensor” nowadays are MIP-related. 
 The main driving forces for the substitution of antibodies with MIPs in sensors are the high 
stability of the polymers and their low price. Typically the lifetime of antibodies is restricted to a 6-12 
months window. They may need to be stored in a refrigerated environment, and antibody-based 
sensors usually cannot be regenerated for more than about 10 cycles. In contrast, MIPs can be stored 
at ambient temperature for years without any noticeable loss in affinity. They can be autoclaved and 
regenerated many times using strongly acidic or basic wash steps or by washing with organic 
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solvents. All these features make them very attractive for use in robust sensors and assays. MIPs are 
also two orders of magnitude cheaper then antibodies. A range of MIPs for different targets are 
available commercially at a price varying from $0.1-0.5 mg
-1
. By comparison, the cost of antibodies 
varies depending on the target but typically lies in the range $100-1000 mg
-1. Even relatively “cheap” 
immunoaffinity cartridges with a low density of immobilised antibodies still demand a relatively high 
price by comparison with MIPs, costing between $10 to $100 mg
-1
.  
There are however some perceived limitations associated with the development of MIP sensors: (i) 
absence of a general procedure for MIP preparation; (ii) difficulty in integrating them with a 
transducer; (iii) difficulty in transforming the binding event into an electric signal. Most of these 
problems however have been addressed in recent years.
19,20
 
 
1.2.1 MIP design 
One of the major problems in MIP design is the choice of an optimal polymerization protocol for the 
development of MIPs. This is mainly because of the need to select and optimise a multitude of 
variable parameters such as the types of monomer to be used in polymer synthesis (more than 4 
thousands polymerisable compounds are commercially available), solvents, temperature, pressure 
etc.
21
 The most advanced approaches available for the selection of appropriate functional monomers 
include combinatorial and computational methods.
22
 In combinatorial approaches the best 
composition is selected on the basis of simultaneous synthesis and testing of tens to hundreds of 
imprinted polymers prepared on a small scale.
23-25
 In the computational approach the monomer 
screening is performed virtually.
26,27
 These two approaches permit the creation of MIPs with affinities 
and selectivities comparable to those of antibodies,
26
 (Table 2).  
 In relation to the molecular imprinting of proteins and cells there is currently insufficient 
evidence from the literature to judge whether combinatorial or computational approaches might offer 
any substantial advantage. In contrast to the recognition of small molecules, which relies on strong 
electrostatic interactions, recognition of large biomolecules and cells is achieved through shape 
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complementarity combined with (weak) van der Vaals interactions and the formation of hydrogen 
bonds.
28
 Thus, most often, imprinting of these species is successfully performed using weakly cross-
linked single monomers such as acrylamide or aminophenyl boronic acid.
29,30
 
  
Table 2. Affinity and sensitivity range of computationally designed molecularly imprinted polymer in 
comparison with antibodies raised against the same target.
26
 
Receptor Kd, nM Sensitivity range, g L-1 
Computational MIP 0.3 ± 0.08 0.1-100 
Monoclonal antibody 0.03 ± 0.004 0.025-5 
Polyclonal antibody 0.5 ± 0.07 0.05-10 
 
The most significant benefits stemming from the use of combinatorial or computational approaches in 
MIP design are reductions in both time and cost involved in the development process. Depending on 
the number of tests required, the typical time needed to develop a novel MIP can be as short as 3-4 
weeks.
31
 
 
1.2.2 Integration with sensors 
The integration of MIPs with sensors can be achieved by in situ polymerisation, using either 
photochemical or thermal initiation,
32
 or by surface grafting with chemical or UV initiation.
33,34
 The 
advantage of this latter approach lies in the possibility of controlled modification of inert electrode 
surfaces with thin films of specific polymers. Polymers can also be electropolymerised on the surface 
of physical transducers. For example, the electropolymerisation of phenylenediamine in the presence 
of glucose was successfully used in the construction of an imprinted sensor for the conductometric 
detection of this compound
35
 (Figure 2). 
9 
 
 Basically, polymers can either be produced separately, for later integration with existing 
(electrochemical, piezoelectric or optical) sensors, or be produced by in situ methods directly on the 
sensor surface. For ease of quality control it is better to produce polymers separately, in a dedicated 
laboratory in the form of membranes or powders, followed by extraction of the template and 
characterisation of the materials obtained. This will follow the modern trend in biosensors 
development whereby the suppliers of biological components are “separated” from the manufacturing 
of detectors and sensor assembly. This model would be difficult to apply for applications where MIPs 
need to be deposited as thin layers, of the order of nanometres, e.g. in evanescent wave sensors.
36
 One 
possible compromise could be the development of methods for the production of MIP nanoparticles, 
“plastic antibodies”, which can be handled by sensor manufacturers in much the same way as 
traditional (natural) antibodies or enzymes.
37,38
 In order to prove the feasibility of this approach, there 
is a need for the development of generic and versatile procedures for the synthesis of MIP 
nanoparticles for various targets. One potential advance in this area could be the development of an 
automated “nanoreactor” for the reproducible synthesis of monodisperse MIP nanoparticles. A reactor 
similar to that proposed here has recently been produced for the preparation of MIP microparticles 
(Figure 3) and it may be possible to tune its characteristics for the production of nanoparticles.
39
  
 
10 
 
 
 
  
Figure 2. Impedance response of the phenylenediamine film imprinted with glucose.
35
 Reprinted from 
Biosensors and Bioelectronics, Vol. 16, Issue 3, Z. L. Cheng, E. K. Wang and X.R. Yang, Capacitive 
detection of glucose using molecularly imprinted polymers, 179-185, Copyright (2001), with 
permission from Elsevier. 
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Figure 3. Flow-focussing microreactor for synthesis of MIP microparticles. Reprinted with permission 
from Ref. 39. Copyright 2009 American Chemical Society. 
 
 
1.2.3 Detection of binding 
Detection of binding is generally realised using electrochemical, piezoelectric and optical transducers. 
Immunosensor-type devices are the most common examples of MIP sensors.
40
 Analyte detection in 
these devices is based on measurements of the template concentration adsorbed by a MIP, 
immobilised on the detector surface. Receptor sensors exploit the ability of a MIP to change its 
conformation upon binding with the template, leading to changes in a measurable property, such as 
conductivity, permeability or surface potential.
17,41
 Alternatively, sensors can be designed that use the 
ability of a functional monomer to change its properties upon interaction with the template; in most 
cases, changes in fluorescence are employed.
42,43
 In one example of this type of material, a fluorescent 
sensor for cAMP detection was constructed using the environmentally-sensitive dye, trans-4-[p-(N,N-
dimethylamino)styryl]-N-vinylbenzylpyridinium chloride)
44
 (Figure 4). The resulting polymer 
displayed both functions of template recognition and sensing. 
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Figure 4. Schematic representation of polymer binding site for cAMP with signalling trans-4-[p-(N,N-
dimethylamino)styryl]-N-vinylbenzylpyridinium monomer.
44
 Reproduced with permission from: 
Piletsky S, Turner A. A New Generation of Chemical Sensors Based on MIPs. In: Piletsky S, Turner 
A, eds. Molecular Imprinting of Polymers. Austin: Landes Bioscience, 2006:64-79. 
 
Several recent publications have described the development of catalytic sensors based on MIPs.  In 
one such study we have used a transition state analogue approach to prepare a MIP with catalytic 
properties similar to the enzyme tyrosinase in the form of an electrochemical sensor for the 
measurement of catechol and dopamine concentration.
45
 Further developments in catalytic receptors 
based on MIPs will depend largely on the successful preparation of MIP-based catalysts which can 
react with water-soluble and practically important analytes.
46,47
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In relation to protein detection, the integration of MIPs with acoustic, surface plasmon resonance or 
surface enhanced Raman sensors might seem to be the most promising platforms.
48,49
 These sensors 
do not require the use of enzyme or fluorescent labels and could be used for the direct measurement of 
analyte concentrations. Alternatively, fluorescent, gold coated or magnetic MIP nanoparticles can be 
used in lateral flow sensor devices as a direct replacement for antibodies.
50-53
 
 
2. Template selection 
When considering proteins as targets for detection by MIP-based sensors, the question arises what is 
the best material to use as a template in order to obtain the required specificity in recognition of the 
target? Since some of these problems are common to decisions about how to raise effective antibodies 
to peptides and proteins, we will first consider in this section what tools are available to those working 
in biological aspects of molecular recognition, followed by a review of how the imprinting has been 
approached.  
2.1 Protein structure, antigenicity and tools for structural analysis 
The antigens bound by antibodies can be classified into groups of smaller, and individually non-
immunogenic, molecules termed haptens, and larger molecules – often proteins. Key early work 
detailing the binding of antibodies and the complementarity determining region (CDR) began with the 
investigation of specificity by Lansteiner and van der Scheer,
54
 the binding of small molecules within 
the hapten binding cleft by Amzel et al.
55
 and the interaction with larger proteins by Amit et al.
56
 
Unlike larger protein molecules, haptens do not induce the formation of antibodies due to the inability 
of B-cells to process the small fragments for presentation to T-helper cells in order to trigger the 
production of various B-cell receptor ligands and cytokines necessary for B-cell clonal expansion, but 
can be used to do so when complexed with a larger molecule, such as a protein.  
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Molecular Imprinted Polymers (MIPs) do not rely on such complex biological signalling for their 
production, thereby providing opportunities to design receptors for a range of molecule sizes, 
including the opportunity to produce receptors to pharmacologically active, or otherwise toxic 
compounds. The aim, when designing synthetic receptors, is to mimic – or even improve upon – the 
specificity of natural antibodies. The binding of antigens to antibodies is well understood, and the 
nature of that interaction (including the important aspects we must consider when attempting to 
design such interactions) is as relevant to synthetic receptors, such as MIPs, as it is to the natural 
molecules. 
 
Regions of a protein that can be classified as antigenic determinants within the structure of a globular 
protein have been called epitopes, a term coined by Niels Jerne, winner of the 1984 Nobel Prize for 
medicine (immunology). It is helpful to also use the term to describe the target region of a protein for 
synthetic receptors.
57
 Early studies
58,59
 showed that natural epitopes of proteins are often found at the 
surface, and this observation appears to hold. Whilst it is clear that only surface residues are available 
to be involved in epitopes, there are several structural arrangements by which this is possible.  
 
The residues which comprise an epitope must be present in a conformation which will be accessible to 
the antigen-binding region (paratope) of an antibody, or to the binding site of a synthetic receptor. The 
residues in the epitope may achieve such a conformational arrangement through spatial proximity 
brought about by the tertiary structure of the globular protein; by their positions within a repeating 
motif of secondary structure such as an alpha helix or beta sheet; or simply by being adjacent residues 
in the primary sequence in a loop or coil region. 
 
Obviously, these arrangements are often mutually exclusive when surface availability is considered. 
Residues which form an epitope should exhibit both spatial proximity within the confines of the 
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conformation of the receptor binding site, and surface availability for binding. It is likely therefore, 
that the epitope brought about by tertiary conformation will be the most common for natural 
antigenicity, given that it is defined by the folded and naturally occurring structure of the protein. 
 
Epitopes which are determined simply through proximity of adjacent residues are, conceptually, 
perhaps the least likely to be observed in natural situations. The arrangement of residues must survive 
the formation of secondary structure motifs, and subsequent folding of the protein into tertiary 
structure. Therefore, for such an epitope to be present in a naturally folded protein, it is unlikely for 
the residues which comprise it to be particularly hydrophobic. A highly hydrophobic residue is more 
likely to be either internalised within the structure, or possibly situated within an alpha helix. The 
helical structure would be either internal, or through its structure have removed the linear availability 
through the helical turns. 
 
Although, a beta sheet would be more likely to retain the local linear structure of such an epitope, the 
characteristics of the other residues within the sheet will influence its position within the tertiary 
structure. Whilst this does not necessarily mean that the availability of the linear epitope will be lost, 
it does mean that the characteristics of the residues which are adjacent to the epitope in the sequence 
will play a large role in determining its availability. 
 
It has been suggested that segmental mobility, or flexibility, is linked to antigenicity,
60,61
 which would 
indicate that the most suitable epitope sites would occur in loop regions of the protein structure. It has 
subsequently been hypothesised however, that any region of a protein that is accessible at the surface 
can potentially interact with an antibody.
62
 More recent studies of antigen-antibody binding have 
suggested that flexibility of the CDR loop regions of the antibody is important for antigen binding.
63
 
This flexibility allows for an „induced fit‟ mechanism for antigen binding, which could logically be 
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aided by flexibility of the antigen structure. Therefore, whilst any surface-available region of a protein 
may have the potential to interact with an antibody, perhaps regions of higher mobility or flexibility 
will afford better affinity with an antibody. 
 
The flexibility that aids antibody-antigen binding is likely to be similarly beneficial to the interaction 
between protein targets and synthetic receptors. The dynamic nature of biomolecules means that some 
movement of the structure is likely either through variations in temperature, solution concentration or 
pressure. The same is, of course, true of the receptor, synthetic or otherwise. MIPs may be rigid, 
highly cross-linked structures or less cross-linked, flexible structures with variable solution content, 
tending towards hydrogels.
64,65
 A flexible MIP may mimic the „induced fit‟ model of the antibody 
CDR, although the nature of the polymer may negate some of the properties leading to robustness and 
longevity inherent in a rigid polymer. By utilising a highly flexible region for the target, some of the 
benefits of the molecular dynamics of the protein can still be exploited even in combination with a 
rigid synthetic MIP receptor. 
 
Whole proteins can be used to raise antibodies or produce synthetic receptors but, whilst this method 
ensures that the receptor is capable of binding the natural form of the protein, there are some 
drawbacks. The main difficulty is in obtaining a purified sample of the protein target with which to 
prepare the receptor. Others may include the solubility of the highly hydrophobic transmembrane 
domains of membrane proteins, the size of the protein, and toxic or otherwise detrimental effects 
caused by the protein on the host animal when considering immunisation methods for producing 
antibodies. 
 
Some of these drawbacks may be overcome by the use of recombinant proteins, but all can be avoided 
by cleavage or synthesis of a fragment of the target protein to create a new target substructure. A 
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receptor for this smaller fragment will still be capable of binding to the native protein, as long as it 
can be ensured that the fragment is a peptide that would ordinarily be available at the surface. For 
artificial receptors such as MIPs, the fragment can be used alone or conjugated to a larger entity, (such 
as a protein, which is necessary when producing antibodies, or, for example a micro- or nano-particle 
or planar surface in the case of MIPs) to influence orientation and cavity generation. When a carrier 
protein is used, a purification step would be required to ensure that affinity for the peptide can be 
selected for, rather than binding to the carrier. 
 
The use of small peptides as „synthetic antigens‟ is attributed to pioneering work by Michael Sela and 
Ruth Arnon during a career of joint publications spanning 40 years. Their use of synthetic antigens as 
a research tool led to better understanding of immunological processes, and specifically autoimmune 
disease, culminating in the development of Copaxone, a drug indicated for the treatment of relapsing-
remitting multiple sclerosis.
66
 Earlier work investigated the use of synthetic antigens comprised of 
poly-amino acids. One such experiment showed that a multi-chain copolymer of poly-DL-alanine 
attached to polypeptides containing L-tyrosine and L-glutamic acid, was strongly antigenic in 
rabbits.
67
 Such a synthetic polypeptide antigen was subsequently used to demonstrate the use of 
Sephadex columns for the purification of antibodies – a technique which is now widely used.68  
 
The activity of antibodies raised to a synthetic antigen was demonstrated for the first time in 1979 
when a fragment of an MS-2 bacteriophage coat protein was used as a synthetic antigen to inoculate a 
rabbit. This approach was successful in raising antibodies reactive to the native protein.
69
 The ability 
to produce protein-specific antibodies from genomic sequence-derived synthetic peptide antigens was 
further investigated by Lerner et al.
70
 The major outer envelope protein of the hepatitis B virus was 
chosen, as the gene sequence was known and the virus was considered to be of interest. The (at the 
time unpublished) computational method of Kyte and Doolittle,
71
 was used to investigate the 
hydrophobicity of the protein, and peptide sequences were chosen from the less hydrophobic regions. 
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Antibodies were produced which reacted to the native protein, the authors speculating that similar 
techniques could produce excellent vaccines. 
 
This work subsequently prompted further investigation of the use of synthetic peptides to raise 
antibodies to important viral targets. Synthetic antigens were chosen from the translated amino acid 
sequence of foot and mouth disease virus after analysis using structure prediction algorithms that was 
cross-referenced with known information regarding serotypes and experimentally-derived natural 
epitopes. The resulting antibodies were shown to specifically bind and neutralise the virus.
72
  
 
So, in order to raise antibodies or design synthetic receptors, a suitable target is required, and there is 
the choice of either using the whole protein, or a fragment of it as the antigen.  
 
If only a fragment is to be used, then there arises the question of how to select the fragment. Natural 
epitopes can be elucidated through experimentation, synthesised and used. Alternatively, any peptide 
fragment may be used if it can be assured that it will be available for binding in the final structure.  
Additionally, the selection of a novel peptide provides the possibility of targeting regions of the 
protein which have not been demonstrated to be antigenic in vivo, but which may offer improved 
access or affinity for detection in sensing applications. 
 
The simplest way to decide if a fragment will be solvent-accessible is to look at its position within the 
tertiary structure of the protein. This is the most suitable approach if X-ray or NMR structural data is 
available in the Protein Databank.
73
 However, as there are currently only around 61,000 structures 
deposited in the database – including many duplications and encompassing many species – it is clear 
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that there is a significant possibility that a target that appears suitable from other experimental or “–
omics” approaches may not have a solved structure (www.pdb.org).  
 
When a protein has no experimentally determined structure, the best method for trying to obtain a 
model of the structure is to compare the sequence to that of a protein of known structure. This can be 
especially successful when the two proteins in question belong to the same family of functional 
proteins. The databases SCOP (Structural Classification of Proteins)
74
 and CATH (Class, 
Architecture, Topology and Homology)
75
 are both linked through the entries in the PDB, and provide 
a classification of protein structures into functional and structural subdomains. Such information can 
be useful when comparing an unknown sequence to partial homologous structures. 
 
When attempting to model tertiary structure based on homology, there are several steps which should 
be undertaken. Initially, a sequence alignment against proteins of known structure should be 
performed, followed by matching the unknown sequence onto the structure of the homologue. Finally, 
optimisation of the structure, in particular modelling of sidechain torsions and interactions and energy 
minimisation of loops needs to be done to refine the model. In order to search for homology to known 
structures, the Fugue tool (tardis.nibio.go.jp/fugue/)
76
 can be used to search the Homstrad database 
(tardis.nibio.go.jp/homstrad/)
77
 of curated protein alignment structures, using other software used for 
the structure determination and optimisation. Alternatively the web-based Swiss-Model 
(swissmodel.expasy.org/)
78
 can be used to align against Homstrad and determine a model in one step. 
 
If the protein in question has no significant homology with another protein of known structure, the 
next logical step is to try and predict elements of the secondary structure from the primary amino acid 
sequence. The current practice of protein secondary structure prediction is dominated by the use of 
neural networks or complex statistical analysis for the determination of residue conformation states, 
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as well as older propensity-based statistical approaches which, whilst being somewhat inaccurate, 
have the benefit of ease of use and being well understood by their end users. Such methods have seen 
continued effort at improvement over the years, but it should generally still be considered a „last 
option‟ approach to resort to predictions of structure from sequences in the absence of homology. 
 
One notable methodology which has been adapted for use as part of an on-line tool (www.embl-
heidelberg.de/predictprotein/predictprotein.html) is that of Rost.
79
 Available as the PredictProtein 
server,
80
 there are several methods available including; PHDsec for secondary structure; PHDacc for 
solvent accessibility; and PHDhtm for predicting transmembrane helix domains,
81
 all of which use 
neural networks for analysis. The author reports accuracies of 72 percent for the PHDsec algorithm, 
and a significant 95 percent for the predictions of PHDhtm. 
 
Despite the growing availability of on-line tools and the popularity of the more complex methods, 
there remains a niche application for some of the „simpler‟ approaches, relying on statistical analysis 
of known structures. These form the basis of many other secondary structure prediction, and antigenic 
region prediction algorithms. 
 
One such well-known algorithm based on statistical propensities is that of Garnier et al.
82
 The GOR 
algorithm uses sets of experimentally-derived scales defining the propensities of amino acids to form 
helix, sheet, turn or coil conformations. The propensity for a given confirmation is compared for each 
amino acid in a sequence, which is then unambiguously assigned to a particular state based on the 
highest of the propensity values. In addition to the statistical propensity approach used by GOR, 
analysis of protein hydrophobicity has also been used to establish general structural features of 
proteins based on empirical evidence of hydrophobic/hydrophilic behaviour of residues. The original 
use of this approach was published by Hopp and Woods
83
 who proposed the use of hydrophilicity as 
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an indication of potential antigenic domains due to their predicted solvent accessibility. The Hopp-
Woods scale was applied using a program originally written in Fortran. The single scale of author-
modified hydrophilicity scales, taken from Levitt,
84
 was applied using a sliding window, equivalent to 
the suggested size of a hexapeptide antigenic structural motif.  
 
A similar approach was detailed by Kyte and Doolittle,
71
 where experimentally-determined values for 
residue hydrophobicity were used to identify internal or transmembrane regions of a protein structure. 
The Kyte-Doolittle scale was implemented using an original program written in C. A single scale of 
assigned hydrophilic/hydrophobic values derived by the authors from water/vapour, water/ethanol, 
and ethanol/vapour free energies for each amino acid, and applied using a sliding window of 7, 9, 11, 
or 13 residues, arbitrarily assigned depending on the size of the structural motif being predicted. The 
hydrophobicity/hydrophilicity analysis techniques are still used, but more often in combination with 
other structure prediction techniques based on propensities of residues to occur in particular structural 
elements.  
 
A list of protein structure prediction algorithms (and other computational analysis tools) is maintained 
at the ExPASy (Expert  Protein Analysis System) proteomics server from the Swiss Bioinformatics 
Institute (www.expasy.org/tools), serving as an excellent starting point for prediction of protein 
structural characteristics. 
 
In addition to the many algorithms which have been written to predict structural conformations, there 
are others which attempt to predict antigenic regions and epitopes of proteins such as the Hopp-
Woods analysis,
83
 mentioned above. It is normal for structural prediction algorithms to be used to 
predict the structure only, and antigenic region prediction methods to be used to identify potential 
epitopes only. In the case where multiple algorithms have been used together, and structural and 
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antigenic prediction methods combined, the full structural analysis is used and added to the 
predictions of antigenicity. 
 
One such method is that developed by Parker et al.,
85
 derived from high-performance liquid 
chromatography (HPLC) of 20 model synthetic peptides, each containing a motif specific to each of 
the 20 naturally occurring amino acids found in proteins. The retention time of the peptide was 
measured and attributed as a measure of hydrophilicity to each amino acid. This scale of 
hydrophilicities was applied using a sliding window assignment modified from Hopp-Woods, in 
combination with a scale of accessibility taken from Janin et al.,
86
 and accessibility values from 
Karplus and Schulz,
87
 as a measure of potential antigenicity. Another example is that of Pellequer and 
Westhof,
88
  which includes analyses from 22 different scales including hydrophilicity, accessibility, 
flexibility and secondary structure propensity. 
 
Perhaps the most well known method which uses a combination of different algorithms is the 
Antigenic Index.
89
 The original algorithm was written in the common, mathematically oriented 
Fortran for the VAX platform. The Antigenic index is calculated from numerical expressions of 
results from slightly author-modified versions of the Hopp-Woods, Janin et al, Karplus and Schultz, 
GOR, and Chou-Fasman
90
 algorithms.  
 
One notable single approach that has not been incorporated into multiple approaches is that of 
Kolaskar and Tongaonkar.
91
  The method incorporates a scale of statistical antigenic propensities 
derived from an analysis of 34 different proteins, with experimentally determined epitope regions, 
applied using a sliding window of seven residues. It is of note primarily because it is so easily 
available to molecular biologists through its inclusion with the European Molecular Biology Open 
Software Suite (EMBOSS) as the programme „antigenic‟ (www.emboss.sourceforge.net). The suite is 
23 
 
widely available and includes many tools for simple and routine bioinformatic analysis useful to 
biological researchers.
92
 Despite being a simple approach, it is popular due to its accessibility, and the 
reported accuracy of 75 percent. 
 
Authors report a wide range of accuracy values for these computational prediction methods, and often 
the performance is evaluated with widely different approaches. Simple methods tend to be fairly 
inaccurate, particularly when testing is re-visited with new evaluation techniques and datasets. 
Clearly, having experimentally determined structural data is the ideal, but where prediction methods 
must be used there is often a compromise to be made between speed and accuracy. It is important to 
consider the methods carefully and be aware of the limitations of the technique. Although perhaps 
obvious, one of the most important things to remember regarding any form of structure prediction is 
that an algorithm which is reported as having 70 percent accuracy is in effect 30 percent inaccurate. 
Of interest perhaps, is the commentary on pitfalls of protein sequence analysis by Rost and 
Valencia,
93
 which discusses many issues surrounding the successful use and interpretation of structure 
predictions.  
 
2.2 Methods of imprinting proteins 
The earliest attempts at imprinting proteins used whole protein molecules as the template. These 
approaches were based on forming a few spatially-separated interactions with specific side chain 
residues on the surface of the protein; such as copper-mediated binding of histidine imidazole 
groups.
94
 In this example a “surface-imprinting” approach was used to avoid encapsulating the 
template, which was dissolved in a DMF/water mixture. N-(4-vinyl)-benzyl iminodiacetic acid groups 
were employed as functional monomer units to chelate copper (II) ions. The chelate groups were 
captured at the surface of vinyl-functionalised silica particles. The imprinted material was shown to 
separate RNase A (template protein) from Lysozyme in an HPLC experiment. This approach was 
similar to that proposed earlier by Arnold and co-workers, who demonstrated the use of copper (II) 
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iminodiacetate groups to recognise a series of bis-imidazoles as protein surrogates.
95-100
 There are a 
number of potential problems with this approach, the first being the use of aqueous DMF as the 
solvent for imprinting a protein. This is by no means a “kind” solvent mixture and many proteins 
would be denatured under these conditions. The use of a small number of strong interactions is also 
not ideal. While there appeared to be separation under dynamic (chromatographic) conditions, any 
protein with surface-exposed imidazole residues would be expected to bind reasonably tightly to 
copper sites on the silica surface. It is likely that non-specific binding would therefore be high for a 
large range of protein molecules. The lack of a three-dimensional element to the surface-bound 
“polymer” is also a limiting factor for good protein recognition (Figure 5). 
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 Figure 5. Proposed “surface imprinting” of RNase A via copper (II) N-(4-vinyl)-benzyl 
iminodiacetate groups at the surface of silica particles functionalised with double bonds. Adapted 
from Kempe et al.
94
 
 
Polymerisation at the surface of silica particles was also employed by Burow and Minoura to prepare 
MIPs for glucose oxidase (GOD).
101
 The aim was to build a thin layer of polymer from a mixture of 
water-soluble cross-linking monomers (N,N'-1,2-dihydroxyethylene-bis(acrylamide) and  N,N'- 
(methylene)-bisacrylamide) in a phosphate-buffered solution of the enzyme template. This approach 
attempted to provide for 3-dimensional recognition and avoided the use of a few strong interactions 
for potentially many weaker ones and was reasonably successful in imparting specific binding to the 
MIP. Rebinding in batch mode showed selectivity for GOD with respect to glucose dehydrogenase 
(GHD) on the MIP and a BSA-imprinted polymer showed the same non-specific interactions with 
GHD.  
 
The group of Hjertén
102
 reported imprinting of whole protein in acrylamide gels prepared with much 
lower levels of cross-linking. These “artificial gel antibodies” as they were later called are relatively 
soft material possessing pores large enough for proteins to diffuse through the polymer, being similar 
in composition to polyacrylamide gels used for protein separation. Hemoglobin, cytochrome C and 
transferrin were used as templates in this initial study. The imprinted gels were granulated by passage 
through 100-mesh sieves and packed into columns in Pasteur pipettes. These small affinity columns 
showed selective binding of the template proteins from mixtures, with high retention of the template. 
High selectively was also demonstrated by the ability to adsorb myoglobin from horse but not whale 
myoglobin on the horse myoglobin-imprinted column, demonstrating selectivity for two proteins with 
similar sequences and 3D structures.
103,104
 The same approach has also been used to prepare imprinted 
gel within the pores of particles made from a more rigid gel (agarose) in order to improve the flow 
rate in chromatography.
105
 “Gel antibodies” prepared by the same approach have been employed in an 
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electrophoretic migration technique with bacteria
106
 and viruses
107
 employed as templates, as well as 
proteins.
108,109
 The migration of the gel particles in a rotating tube under an electrophoretic field 
depends on their overall charge. Since the acrylamide particles are neutral they only become charged 
and can migrate in the electric field when they rebind their respective templates. The use of the 
materials in clinical diagnosis and the detection of protein biomarkers was recently demonstrated
110,111
 
and the approach was also shown to be applicable to the preparation of enzyme reactor beds.
112
 The 
later paper also suggests that “renewable biosensors” for viruses, bacteria and spores could easily be 
created using the gel antibody approach. 
 
A “whole” protein approach was also reported by Venton and Gudipati,113 using a mixture of silane 
monomers, 3-aminopropyltriethoxysilane and tetraethylorthosilicate (1:3), to prepare a siloxane 
polymer in the presence of urease or bovine serum albumin (BSA). The polymers became entrapped 
in the polysiloxane matrix and were also probably covalently bound to the polymer through reactive 
side chain residues. Template species were removed by digestion with pronase and a moderate 
selectivity in rebinding was seen in binding experiments with the two proteins and their respective 
imprinted polymers. Attempts to reproduce this result with the protein couple haemoglobin and 
myoglobin did not show any selectivity however.  
 
Compared with other methods, the use of whole protein in solution presents few advantages as a 
general approach to preparing MIPs for sensor applications. The main advantage is that the template 
structure will most accurately reflect that of the target (assuming the target and template are the same 
protein) however this is largely outweighed by a number of disadvantages namely: the template may 
easily become entrapped or covalently bound to the polymer, it may be difficult to maintain the native 
conformation of the protein throughout the polymerisation process and the large imprinted sites may 
be seen as general nanopores, able to bind a range of smaller polypeptides, resulting in reduced 
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selectivity. For these reasons, a number of other strategies, involving surrogate templates, have been 
employed. 
 
 
 
Figure 6. Schematic diagram of epitope imprinting: a short peptide sequence is used as the template 
to create selective binding sites for a larger peptide or protein. Adapted from Rachov and Minoura.
57
 
 
An alternative to the use of whole protein as template is the “epitope approach”, originally proposed 
by Rachov and Minoura.
57,114-116
 In this method a peptide with the same sequence as one of the 
terminal chains of the target protein (the epitope) is used as a surrogate template for the whole protein 
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(Figure 6). This approach is analogous to protein recognition by antibodies, where an “epitope” of the 
immunogenic protein is the site of antibody binding, not the whole protein. In the imprinting context 
the template peptide generally represents one of the terminal sequences of the primary protein 
structure, although an antibody epitope could be any surface-accessible region of the target protein. 
Terminal peptides make better imprinting targets because their structure is unambiguously defined 
and relative to other regions of the target protein, they will have fewer interactions with the protein 
secondary structure, which may hinder or frustrate binding. The minimum length of peptide necessary 
to create “unique” recognition for the target protein has been estimated to be around 9 amino acids 
according to Nishino et al.
117
 These authors also state that an exposed C-terminus is preferable, since 
this site is less prone to post-translational modifications.
118,119
 While Nishino et al.
117
 used 
nonapeptide epitopes as template, peptides as small as tri-
120
 and tetra-peptides
114
 and as large as 15-
121
 or 16-
122
 amino-acid units have been used to target other proteins. 
 
The surface imprinting method applied by Nishino and co-workers
117
 (Figure 7) was shown to be 
effective at selective extraction of the target protein from mixtures, such that Cytochrome c (Cyt c), 
alcohol dehydrogenase (ADH) and bovine serum albumin (BSA) were found to be selectively 
captured by polymers imprinted with their respective C-terminal peptide epitopes from mixtures 
containing five proteins. The templates were: AYLKKATNE (Cyt c from bovine-heart, amino acids 
97–104), AYLKKATNE (ADH from yeast, amino acids 339–347) and VVSTQTALA (BSA amino 
acids 599–607). Each was immobilised by its N-terminus on a planar Si/SiO2 surface through 
coupling to a carboxy-functionalised silane linker. Photopolymerisation of an acrylamide/ethylene-
bis-acrylamide polymer thin film at the surface produced the imprinted layer which could be peeled-
off the template assembly to reveal the binding surface. Rebinding was also shown to be sensitive to 
substitution of one amino acid residue and non-specific binding to the imprinted surface was low. 
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Figure 7. The surface-bound epitope approach employed by the group of Shea using C-terminal 
nonapeptides as templates for protein imprinting. Selective binding of the target proteins (Cyt c, ADH 
and BSA) was demonstrated from mixtures of Cyt c, ADH, BSA, carbonic anhydrase and trypsin 
inhibitor. Adapted from Nishino et al.
117
 
A number of advantages therefore stem from using terminal peptide epitopes as the template, namely: 
the conformation of whole protein does not need to be retained, allowing harsher solvent and 
temperature conditions to be used; selectivity in protein recognition can be controlled by the choice of 
epitope and its length; template removal is far more easily achieved than with whole protein and 
highly selective imprints can be obtained. On the other hand, a good knowledge of the protein 
structure is necessary, but as we have seen from the earlier discussion, there are a number of 
computational and database-based methods available which can help. Another limitation is that 
custom synthesis may be required in order to prepare the templates which may be relatively costly and 
time-consuming.  
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2.3 Template presentation  
For the imprinting of small molecules it is usually sufficient to dissolve the template, monomers and 
initiator in a porogenic solvent prior to the formation of MIPs, whether the resultant material is to be a 
monolith, bead, film or membrane. This approach can be followed when imprinting proteins or their 
epitopes, but the results are likely to be suboptimal due to a number of phenomena: protein 
entrapment, resulting in poor template removal and steric hindrance limiting rebinding of bulky 
protein molecules being just two. For these reasons it is preferable to form imprints for protein 
binding at surfaces or interfaces between phases to overcome these problems. 
 
Imprinting methods at a planar surface or interface can be termed 2-dimensional approaches. These 
include the capture of protein complexes at existing surfaces, as in the example shown in Figure 5,
94
 
and the organisation of surfactant-like molecules in Langmuir monolayers.
123
 While these 2-D 
imprints can show some selectivity, it is unlikely to ever be a suitable method for sensing 
applications, as non-specific binding is always likely to be high with such materials.  
 
A degree of three-dimensional imprinting of whole protein can be achieved with “surface imprinting” 
methods. A good deal of ingenuity has been shown in the devising of methods for the partial 
embedding of protein templates in polymer without complete encapsulation. These methods include 
contact printing and interfacial methods. A number of these are summarised in the graphic below 
(Figure 8). These examples cover a wide range of materials in which the imprints are made: plasma-
polymer,
124
 metal,
125
 polysilanes,
126
 poly(acrylamide)
127
 and poly(dopamine)
128
 as well as a diverse set 
of techniques to prepare imprints on planar surfaces,
124,125,127
 beads
126
 and nanowires
128
 with various 
degrees of complexity involved in their realisation. That these lengths are worth going to can be 
related to the likely cost of templates and their efficient use as well as the ready accessibility of the 
imprint sites. The same considerations equally apply to the imprinting of epitopes as to whole 
proteins, the templates may also be expensive and/or available in small amounts and the target is still 
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a bulky protein molecule (See Figure 7). An interesting strategy for the imprinting of peptides at 
surfaces was reported by Titirici et al.
129
 using solid-phase synthesis on a porous silica bead to 
produce the template peptide in situ, before the imprinting polymerisation was carried out in the pores 
of the silica. Etching away the macro-template (silica bead) gave (negative) replicas of the pore 
structure of the template particle with surface accessible imprint sites. The imprints were shown to be 
capable of binding larger peptides with the same terminal sequence as the template peptide 
(epitope).
130
 This method is a development of that shown for small molecules
131,132
 and is also similar 
in concept to the nanowire method, shown in Figure 8. 
 
When considering the pros and cons of bulk vs. surface imprinting methods, the following should be 
considered: Bulk imprinting is a fairly simple approach compared to surface-imprinting methods, 
which may require much more complex preparation procedures. Bulk methods are inefficient in their 
use of potentially expensive templates, whereas surface-confined templates may be used more 
efficiently and, although as yet largely unproven, could possibly enable template reuse though a 
number of imprinting cycles. Template removal should be much easier to achieve in surface-confined 
imprinting, providing good access to the imprinted sites, whereas MIPs prepared in bulk may suffer 
from poor template extraction, slow binding kinetics and template entrapment and/or bleeding. 
Surface methods may also offer lower non-specific binding but ultimately the number of binding sites 
created will be limited by the amount of surface available. Whether this would prove to be a limitation 
will depend on the ultimate application of the material and (for a sensor) the signal transduction 
method used. 
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Figure 8. Various protein surface-imprinting methods: A) Method of the group of Ratner
124,133
 
involving imprinting in a plasma-polymerised film using disaccharide units as the species providing 
functional group interactions with the protein surface. Adapted from Shi et al.
124
 B) The formation of 
“molecular mirrors” by casting replicas of protein molecules adsorbed on mica surfaces using molten 
gallium.
125
 C) Surface grafting of polymer around template molecules immobilised on silica beads, 
according to the method of Shiomi et al.
126
 A similar strategy was employed by Bonini et al. in the 
surface imprinting of human serum albumin (HSA) using poly(3-aminophenylboronic acid) as the 
recognition material.
134
 D) Surface micro-contact imprinting method developed by the group of 
Chou.
127
 E) The formation of surface protein-imprinted polymer nanowires by hierarchical templating 
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using proteins anchored to the inner walls of membrane nanopores as molecular templates. Adapted 
from Ouyang et al.
128
 
 
2.4 Environmental factors 
 
For the imprinting of whole protein, careful control over pH and salt concentration may be required to 
preserve the native conformation of the template protein and control the charge state of the protein. 
Such precise control may not be necessary for epitope imprinting however, depending on the 
functionality of the constituent amino acids and indeed whether aqueous or non-aqueous 
polymerisation conditions are utilised.  
 
Uysal and co-workers
135
 prepared haemoglobin-imprinted polymers at different pH (4.0, 6.8 and 8.0) 
to study the effect of pH on the imprinting process. They used t-butylacrylamide, acrylamide and 
itaconic acid (ITA) as functional monomer. It was found that the greatest binding for the template 
protein was shown by the polymer imprinted at pH 4.0, below the isoelectric point of the template, (pI 
= 6.8) where the protein carried a net positive charge, enabling its interaction with the negatively 
charged ITA residues. 
 
3 Polymer selection 
The recognition properties of MIPs are highly dependent on the quality of the binding sites contained 
in the matrix and this applies equally to MIPs imprinted with proteins. Key factors governing the 
quality of the imprinted cavities are the choice of monomers and cross-linkers as well as their 
amounts. The following sections describe strategies for monomer selection and survey of a number of 
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recent papers showing the diversity of compositions used to imprint proteins and other biological 
targets. This is followed by a consideration of the cross-linkers used in the imprinting of proteins. 
 
3.1 Choice of functional monomer 
There are many monomers available for interaction with template functionality and in general their 
selection can be made by selection, based on chemical intuition according to the structure of the 
template, or on the basis of molecular motifs for which designed small molecule receptors have been 
published.
136-138
 Alternatively a rational selection can be made, either using a combinatorial 
(experimental) approach,
23,24
 a chemometric experimental design
24
 or by computational methods.
26,139-
142
 In the combinatorial and chemometric approaches libraries of MIPs with different compositions are 
prepared, either as a comprehensive (combinatorial) or representative (chemometric) set, varying 
parameters such as functional monomer, monomer-template ratio, solvent, cross-linker etc. Evaluation 
of the polymer properties, such as extent of binding of the template, can be made using semi-
automated approaches. Computational methods however use computer modelling in an attempt to 
predict the locations and strength of the interactions of monomer with template. Selection of which 
monomer to use can then be based on criteria such as binding energies and number of points of 
interaction. Selection of monomers for protein imprinting, however, is complicated by factors which 
do not apply when small molecules are to be imprinted. Firstly, as most proteins are not soluble in 
non-polar or medium polarity solvents, only monomers which are soluble in polar solvents (ideally 
water) can be selected. Even when the protein target can be dissolved in an organic solvent, it would 
be unwise to use it the production of MIPs, since biomolecules are highly likely to undergo 
conformational changes
143
 such that the resulting imprint will not be representative of the native 
protein target in aqueous solution, where the sensor is most likely to be required to perform. 
Disregarding monomers soluble in apolar organic solvents, many of the remaining monomers of the 
functional monomer “pool” contain ionisable groups (strong acids and bases). Whether polymers 
containing these highly charged monomers are helpful in the imprinting of proteins has been of some 
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debate. In fact whereas, relatively strong non-covalent interactions can arise from electrostatic 
interaction of opposing charges on polymer and template, a net positive or negative charge on the 
polymer can also lead to high levels of non-specific interaction for all species carrying the opposite 
charge, since many of the charged monomers will be randomly distributed over the polymer surface, 
as well as being specifically located in the imprinted sites. This situation is generally incompatible 
with cases where the target protein must be detected from a mixture of similar molecules, as is usually 
the case for biomedical use. In fact smaller charged species, such as physiological salts and buffers 
could interfere with recognition based largely on charge. For these reasons the majority of successful 
protein imprinting experiments have used neutral, water soluble monomers such as acrylamide and its 
derivatives or other neutral monomeric species (see Table 3). 
 
Table 3. Examples of protein imprinting taken from the literature and the functional monomer 
composition used in the imprinting step. 
Monomers Protein/Template 
2-methacryloyloxyethyl phosphorylcholine  
and 2-methacryloyloxyethyloxy carbonyl  4-
phenylazide 
 
Fibronectin
144
 
chitosan and acrylamide 
haemoglobin and bovine serum albumin (BSA)
145-
148
(see however Ref. 149) 
Acrylamide 
 
bovine haemoglobin,
150-152
 Staphylococcus aureus 
protein A,
153
 cytochrome C,
154
 lysozyme,
155,156
 
human serum albumin,
157
 BSA
156
 
acrylamide (hydrogels) 
 
cytochrome C, transferrin and haemoglobin
102
 
acrylamide, methacrylic acid and 2-
dimethylamino ethyl methacrylate  
Lysozyme
158
 
acrylamide and 4-vinylpyridine BSA
159
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acrylic acid* and acrylamide  Anthrax protective antigen
160
 
acrylic acid,* acrylamide and N-
benzylacrylamide 
Protein 1 of flavivirus (Dengue Virus)
121,161
 
acrylamide and epichlorhydrin cross-linked 
chitosan 
albumin
162
 
N-isopropylacrylamide, acrylamide and 
methacrylic acid * 
lysozyme and cytochrome c
163
 
3-aminopropyltrimethoxysilane and 
trimethoxypropylsilane 
Haemoglobin
126
,  
11-mercapto-1-undecanol 
 
myoglobin and haemoglobin,
164
 
carcinoembryonic antigen
165
 
3-aminophenylboronic acid 
 
bovine haemoglobin and BSA,
159,166-169
 papain and 
trypsin,
170
 microperoxidase, horseradish 
peroxidise, lactoperoxidase and haemoglobin,
171
 
-lactoglobulin,172 lysozyme and haemoglobin,173 
lysozyme or cytochrome C
174,175
 
Poly(ethylene-co-ethylene alcohol) albumin and lysozyme
176
 
Poly(ethylene-co-vinyl alcohol) -amylase177,178 
N-[3-(dimethylamino) propyl] methacrylamide 
and N-isopropylacrylamide 
 
BSA
179,180
 
3- aminopropyltriethoxysilane human serum albumin
134
 
3-aminopropyltriethoxysilane and 
tetraethoxysilane 
Ricin
181
,  
3-aminopropyltrimethoxy 
siloxane and tetraethoxysiloxane 
 
BSA
182
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aminopropyltrimethoxysilane and tetraethyl 
orthosilicate 
 
bovine haemoglobin
53
 
3-aminosilane and tetraethosysilane and 
octyltrimethoxysilane 
BSA
183
 
3-aminosilane and tetraethosysilane and 
octyltrimethoxysilane 
Staphylococcus enterotoxin B
184
 
phenyltrimethoxysilane and 
methyltrimethoxysilane 
human serum albumin
185
 
acrylamide , 3- aminopropyltriethoxysilane albumin, hemoglobin and cytochrome C
186
 
acrylamide, methacrylic acid* and 2-
(dimethylamino)ethyl methacrylate  
lysozyme
187
 
Poly(ethyleneglycol dimethacrylate) and 
methacrylic acid* 
Ovalbumin
188
 
methacrylic acid,* Poly(ethyleneglycol 
dimethacrylate) 
creatine kinase
189
 
acryloyl--cyclodextrin, acrylamide  lysozyme, haemoglobin190,191 
methylmethacrylate and tetraethylene glycol 
dimethacrylate 
myoglobin
192
 
N-isopropylacrylamide, acrylamide and 4-
vinylpyridine 
BSA
193
 
N-methacryloyl-L-tyrosine methyl ester and 2-
hydroxyethyl  methacrylate 
Hepatitis B surface antibody
194
 
N-isopropylacrylamide and 2-acrylamido-2-
methyl propane sulfonic acid* 
 
myoglobin
195
 
3-methacrylamido propyltrimethyl ammonium 
or 2-acrylamido-2-methyl propane sulfonic 
bovine hemoglobin
196
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acid* 
N-methacryloyl-L-histidine methylester lysozyme
197
 
methacrylic acid* and ethylene glycol 
dimethylacrylate 
BSA
198
 
methacrylic acid* and trimethylolpropane  cell adhesion proteins
120
 
methyl methacrylate, methacrylic acid* styrene, 
tetraethylene glycol dimethacrylate and 
ethyleneglycol dimethacrylate as cross linkers 
myoglobin, lysozyme and ribonuclease A
199,200
 
N-[3-(dimethylamino) 
propyl]methacrylamide and methacrylic acid* 
BSA and lysozyme
201
 
Agarose BSA
202
 
acrylic acid*  lysozyme
203
 
methyl methacrylate ribonuclease A, BSA, lysozyme
204
 
methyl methacrylate and ethylene glycol 
dimethacrylate 
ribonuclease A
205
 
Styrene, divinylbenzene and methacrylic acid* lysozyme and Tobacco Mosaic Virus
28
 
styrene  ribonuclease A
206
 
2-acrylamido benzamide CYP2D6 isomer of Cytochrome P450
207
 
6-(N-acrylamido)-6-deoxy--cyclodextrin angiotensin II208 
N-acryloyl p-aminobenzamidine and acrylamide trypsin
209
 
O-(4-nitrophenylphosphoryl) choline C-reactive protein
127
 
Poly(vinyl alcohol)-based assistant recognition 
polymer chains (ARPCs),  
BSA
210,211
 
*Charged monomer 
Table 3, above lists the functional monomers used in the molecular imprinting of proteins. These can 
be roughly divided into: acrylic monomers, such as acrylamide, used to produce polymers, either in 
water (e.g. hydrogels) or in organic solvents; silane-based monomers, to create sol-gels, organically-
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modified silicas (ORMOSILs) and related materials; monomers such as 3-aminophenyl boronic acid, 
used to make imprinted polyaniline; and thiol derivatives and surfactants used in the formation of “2-
D” imprints at interfaces or on gold surfaces, the latter mainly for sensor applications. The majority of 
the monomers used are either neutral compounds or weak acids or bases, which will be uncharged 
over a relatively wide pH range.  There are relatively few examples (marked with a star in the table) 
where monomers that are likely to be significantly charged at neutral pH, were used for imprinting.  
 
Janiak et al.,
196
 recently looked at the effect of charge density on the recognition properties of 
molecularly imprinted hydrogels, prepared using either positively or negatively charged monomers 
(3-methacrylamido propyltrimethyl ammonium or 2-acrylamido-2-methyl propane sulfonic acid) 
respectively. The gels showed a decrease in recognition ability with increasing charge density, which 
also affected the swelling behaviour of the gels. The authors also showed that surfactants, generally 
employed in the template removal process, were responsible for some of the binding interactions seen. 
 
Ou et al.
187
 have shown that when hydrogels (polyacrylamide materials produced in aqueous 
environments) imprinted with lysozyme were prepared using acrylamide as the only monomer, the 
protein molecules were partially incorporated through covalent bonding to the polymer matrix, 
occurring during the polymerisation, and could not be removed. This limited the number of 
recognition sites available for specifically rebinding the template. This phenomenon could be reduced, 
however, by the inclusion of methacrylic acid into the hydrogel compositions. This was attributed to 
the acidic monomer interacting through electrostatic forces with groups on the protein responsible for 
formation of covalent bonds, making them unavailable to attack by radicals during polymerisation. 
Chen et al.
163
 also used a small amount of methacrylic acid as copolymer, alongside N-
isopropylacrylamide as the major functional monomer, in order to synthesise hydrogels specific for 
lysozyme and cytochrome C. Matsunaga et al.
203
 similarly produced lysozyme-imprinted hydrogels 
films on a sensor surface using an acidic monomer, acrylic acid. In addition to the acidic monomer, 
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the zwitterionic monomer, 2-methacryloylethyl phosphorylcholine, was included in their polymer 
composition in order to reduce non-specific binding to the hydrogels. The same group
212
 investigated 
the role of acrylic acid in the imprinting of lysozyme on the surface of silica beads using acrylamide 
and N,N-methylene-bis-acrylamide based polymers. They concluded that a ratio of 5:1, 
acrylamide:lysozyme was optimal and that in the absence of acrylic acid there was no binding 
specificity in the polymers, whereas too much of the monomer gave rise to high non-specific binding. 
On the other hand Zhang et al.
190
 were able to produce MIPs for lysozyme using only a mixture of 
acrylamide and acryloyl--cyclodextrin, another neutral monomer. The authors managed to avoid the 
problem of lysozyme incorporation into the matrix by covalently immobilising the template onto 
silica beads, making it less available to radical attack. The material synthesised by Zhang and 
colleagues showed high specificity and excellent selectivity for rebinding of the template with respect 
to other proteins (cytochrome C, BSA, avidin and methylated bovine serum albumin).  
Another study that lends weight to the proposition that acrylamide (usually with methylene-bis-
acrylamide as cross-linker) is the monomer of choice for protein imprinting, is that reported by the 
group of Ulbricht.
213
 They showed that highly cross-linked layers of polyacrylamide grafted on 
sensors, strongly reduces the adsorption of protein (BSA) compared to bare sensor surfaces, making 
this material very promising for the development of sensors for protein detection.  
Turan et al.
195
 produced hydrogels with specificity for myoglobin, prepared using N-
isopropylacrylamide along with the strongly acidic monomer, 2-acrylamido-2-methyl-propanesulfonic 
acid (AMPSA) as the functional co-monomer. Although the authors showed that this composition 
produces selective hydrogels in model solutions, it would been interesting to see the behaviour of 
their material in a complex biological fluid. This would make it possible to assess whether the 
presence of negative charges, due to the presence of AMPSA, would lead to high levels of non-
specific binding. 
Other examples, cited in Table 3, involving the use of charged monomers, are those in which surface 
imprinted layers, thin films or self-assembled monolayers (SAMS) have been prepared. These can 
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generally be classed as 2-dimensional or 2-D MIPs. In these 2-D MIPs, non specific binding, which 
can result from the presence of charges generally distributed over the surface of porous polymer 
particles, is minimised by limiting the amount of available surface. Molecularly imprinted films 
specific for creatine kinase and ovalbumin were made by „micro-contact imprinting‟ by the group of 
Chou
188,189
 using methacrylic acid as monomer. These molecularly imprinted films were able to 
maintain their recognition capabilities even when tested in undiluted serum. Tai et al.
121,160,161
 
produced MIP films based on a mixture of acrylamide and acrylic acid for a variety of targets onto 
quartz crystal microbalance sensors. These examples have therefore shown that for sensor 
applications, where 2-D MIPs films are used for the recognition of target analytes, using acrylamide 
as the principal functional monomer, accompanied by a small amount of a strongly basic or acidic co-
monomer, can produce better sensing materials. The implication is that combinatorial approaches and 
computational modelling can also be used in the design of polymer compositions for protein 
imprinting, as well as for small molecule targets, to help in the selection of the “best co-monomer” for 
a specific target protein (or peptide). 
For completeness some of the more unusual systems reported for protein imprinted should be 
mentioned here. The first is the use of so-called “assistant recognition polymer chains” (ARPCs), used 
in the imprinting of BSA
210,211
 and cloned pig cyclophilin 18.
214
 These are poly(vinyl alcohol) chains 
modified, with polar functional groups and double bonds, which are allowed to interact with the target 
protein before being immobilised onto the surface of a macroporous adsorbent sphere through a 
polymerisation process. The use of a range of ARPC structures allows a selection of the best binding 
chains on the basis of competition before polymerisation. Another unusual approach is the 
photochemically-induced templating of proteins into a polymer bearing cis-trans photoisomerisable 
azobenzene side-chains.
215
 Irradiation of the polymer in the presence of proteins,
215-217
 viruses
218
 or 
polymer beads
215
 causes the polymer to deform as it undergoes repeated photoactivated 
conformational changes, resulting in immobilisation of proteins and/or the formation of photo-
imprints. While scientifically interesting, the system is unlikely to be relevant to sensor construction 
as the polymers remain photo-active after template removal and would therefore be prone to “erasure” 
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of the imprints through stray light activation. The final system worth mentioning is the “antibody 
replicas” prepared by the group of Dickert.219,220 In this case imprints of antibodies for a specific target 
were prepared in particles of poly(vinylpyrrolidone-co-methacrylic acid) crosslinked with N,N‟-(1,2-
dihydroxyethylene)-bisacrylamide. The antibody-imprinted particles were used as a stamp in the 
formation of a secondary imprint as a polymer layer on the surface of a sensor chip. Remarkably the 
plastic replica antibodies were claimed to show improved selectivity and sensitivity on quartz crystal 
microbalance sensors when compared to their natural counterparts (the original templates).
219
 This 
approach has the advantage that potentially many copies of the antibody replicas can be prepared, 
however it suffers from the disadvantage that antibodies must first be prepared as the template 
species, which tends to negate many of the attractions of using imprinting in the first place, in 
particular dispensing with the need to use laboratory animals and/or expensive and time-consuming 
biological processing. Clearly this approach is relevant to sensor preparation, but at the moment is a 
curiosity. 
 
3.2 Cross-linkers and cross-linking 
There are two principal approaches to protein imprinting, either the use of a relatively high degree of 
cross-linking to make rigid or semi-rigid polymeric materials or to use lower amounts of cross-linking 
agent to prepare soft hydrogel materials that need to remain hydrated to retain memory for the 
template. A compromise situation can arise when grafting low cross-linked polymer to a solid 
support, such as a porous membrane, since this adds a local degree of order at the interface, 
maintaining the structure more efficiently than an unsupported soft gel.  
 
For sensing purposes, soft hydrogels are unlikely to be practicable, since they require constant 
hydration and are readily damaged. Byrne and Salian recently reviewed the area of protein imprinting 
in hydrogel polymers.
221
 The authors predict a rapid rise in the number of publication in imprinted 
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hydrogels, based on current trends, although there are clearly some problems associated with working 
with soft gel materials. 
 
 
 
 
Figure 9. Structures of some of the cross-linkers mentioned in this section: MBA: methylene-bis-
acrylamide; EBA: ethylene-bis-acrylamide; BAP: bis-acryloylpiperazine; EGDMA: ethyleneglycol 
dimethacrylate; NOBE: N,O,-bis-methacryloyl ethanolamine; TEGDMA: tetraethylene glycol 
dimethacrylate. 
 
For aqueous-based polymerisation there are relatively few compounds available for use as cross-
linker, the principal candidates are: methylene-bis-acrylamide (MBA), ethylene-bis-acrylamide 
(EBA) and N,N‟-bis-acryloylpiperazine (BAP).  
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MBA is commonly used in the cross-linking of polyacrylamide gels for electrophoresis applications 
and has been used, for example in the “gel antibodies” of Hjertén.103 The monomer performs well as 
an aqueous-compatible cross-linker but suffers from relatively poor solubility, preventing one from 
achieving relatively high levels of cross-linking when used alone. EBA is more soluble in water and 
BAP has an even higher solubility. 
 
Burow and Minoura
101
 used MBA in combination with N,N‟-1,2-dihydroxyethylene-bis(acrylamide) 
in the imprinting of glucose oxidase on the surface of silica beads. EBA was used as the cross-linker 
in the work of Nishino
117
 on epitope imprinting at a surface layer. The cross-linker was used at the 
level of 10%, and polyethylene glycol 200-diacrylate was also added at the level of 0.1 mol%.  El 
Kirat and co-workers
154
 compared the binding capacity and specificity of a number of cytochrome c 
imprinted polymers, prepared using a range of cross-linkers, including MBA, EBA and BAP. The 
optimum varied for each cross-linker studied, but was in the range of 3.3 to 6.6% in each case. The 
highest binding was seen in the case of 6.6% EBA, which also showed reasonably low non-specific 
binding. 
 
Lin et al.
199
 based the selection of cross-linker in their work on the microcontact imprinting of 
myoglobin by finding the cross-linker with the least affinity for their template. On this basis 
tetraethylene glycol dimethacrylate (TEGDMA) was chosen as cross-linker. Methyl methacrylate was 
chosen as functional monomer and the MIP showed excellent specificity and good selectivity for the 
template.  
 
In organic solvents, the cross-linker of choice is usually ethyleneglycol dimethacrylate (EGDMA) 
although the use of hybrid cross-linkers
222
 is an interesting option. In particular N,O-bis-methacryloyl 
ethanolamine (NOBE)
223
 has proved useful in the preparation of OMNiMIPs (one monomer 
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molecularly imprinted polymers),
224
 which have shown good performance in the enantioselective 
imprinting of amino acid derivatives and other chiral templates.
225
 More recently this approach was 
shown to give specific recognition materials for peptides, indicating that NOBE may be useful for 
applications in epitope imprinting for binding larger protein targets.
226
  
4 Polymer preparation 
The choice of thermal or photochemical polymerisation conditions may be dictated by the polymer 
format. For example surface grafting, which is preferable for sensor applications, is often 
conveniently carried out by photochemically-activated graft polymerisation, using surface-bound 
initiators. While high temperatures can be reached inside bulk polymerisations,
227
 which would be 
damaging to protein templates, this should not be the case with thin polymer films where the heat can 
be more efficiently dissipated. The polymerisation time and initiator concentration can be optimised 
by experiment, although low initiator concentrations and longer polymerisation times have been 
shown to be beneficial in the imprinting of low molar mass compounds.
228
  
Once polymerisation is complete the template molecule (the protein or peptide) must be extracted 
with a suitable solvent in order to allow the specific recognition sites created by the imprinting 
process to be available for binding. The washing conditions used for template removal need to be 
carefully selected in order to preserve the integrity of the imprint sites, while removing as much 
template as possible. Mildly acidic and/or basic solutions, as well as various surfactants and 
enzymatic digestion methods have been employed for the removal of protein templates. Mildly basic 
conditions (a solution of NaOH/NaClO (0.5/1.0%) for 0.5-2 h) were used by Shi et al.
124
 to dissolve 
and extract the protein templates from a disaccharide-based MIP layer. Successful rebinding of the 
template proteins suggested that indeed the mild washing solution succeeded in freeing specific 
binding sites without any damage. Janiak et al.
196
 pointed out that surfactants, also widely used for 
template removal, in addition to washing out the template molecule, can be responsible for some of 
the binding properties attributed to imprinting. This also highlights the need for careful use of controls 
when interpreting binding to specific interactions with MIPs. Protein digestion approaches, using 
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enzymes such as pronase
113
 or trypsin,
150
 run the risk of leaving template fragments attached to the 
polymer. The use of enzymes, even those that are relatively small proteins, also means that some 
template will be inaccessible to the removal agent, especially if MIPs are in a “bulk” or 3-dimensional 
format. This should be less of an issue for very thin (2-D) MIP layers. Surface imprinting approaches, 
such as the microcontact printing method, can simplify template removal, since most is peeled away 
with the substrate used to present the templates to the polymerisation mixture.  
Regeneration of the imprint sites after a binding event involves very similar issues to those concerned 
with template removal. If the MIPs are to be used in reusable sensors, an efficient regeneration step 
will be required. In many practical applications of sensors (e.g. for medical use) a disposable (one-
shot) system would be preferable, both for operational and safety reasons. In this case how to 
regenerate the MIP would no longer be an issue.  
A fundamental feature of a successful sensor is its selectivity: insufficient selectivity can lead to false 
negatives. In the case of MIP-based sensors the imprinting approach must be selected so as to 
maximise selectivity. In protein recognition, selectivity impinges on the ability of the MIP sensor to 
recognise only the target protein or a protein family. In practical terms, this means that the affinity of 
the polymer for the target must be considerably greater than for any non-target protein. Despite the 
numerous examples reported in the literature, in our opinion, it will be highly unlikely that sufficient 
selectivity would be achieved using a whole protein approach. Probably the best way to ensure a high 
degree of selectivity is to prepare MIPs for use in biosensors using the epitope approach,
57,114-116
 as 
described above. In this case maximum selectivity in binding can be achieved through selection of a 
peptide epitope of sufficient length such that it is as close as possible to being a unique identifier of 
the target protein as possible, within the bounds of probability; but not so long that binding will be 
sterically hindered or require considerable reorganisation of the protein structure.  
Whereas high selectivity avoids false negatives, a high specificity (or low non-specific binding to the 
non-imprinted regions of the transducer coating) will avoid false positives. The specificity will 
therefore depend on the exposed surface area of the polymer, its functionality and surface charge, 
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among other factors. As it has been already explained above, it is suggested that the avoidance of 
charged monomers (and initiator) might help in reducing non-specific interactions. This also applies 
to the use of charged surfactants for the removal of template. A dense array of epitope-imprinted sites, 
as described by Nishino et al.
117
 is also to be recommended. 
4.1. Polymer format for sensing applications 
The format of the polymer used in protein imprinting is usually dictated by the method of 
polymerisation and how the template is presented (surface or interfacial imprinting approaches) or the 
application (surface-grafted films on transducer surfaces or beads for chromatographic separations). 
Several examples of surface-grafted protein imprinting films are reported in the literature, where 
either the protein or the peptide, representing part of the protein (epitope approach), are mixed with 
monomers and in some cases also with a cross-linker (e.g. N,N-methylene-bis-acrylamide) and 
polymerised in situ to form grafted films on transducer surfaces or on supporting particles. Different 
type of monomers have been used for this type of surface-grafted sensor and among the most common 
are: thiol derivatives;
164,165
 silane derivatives;
53,126,182,184,185
  boronic acid;
157,166,167,170
 and acrylics such 
as acrylamide or N-isopropylacrylamide.
121,154-156,160,162,180,203
  
Surface-constrained templates, as required by contact imprinting
127,189,199
 and surface confined epitope 
approaches
117
 are probably the most readily adapted to incorporation with transducer surfaces. In 
these cases a planar thin film results from a casting process, polymer-forming components being 
confined as a thin film between surfaces, one treated to bind to the polymer (corresponding to the 
transducer surface) and the other, bearing the template structure, allowing easy release. 
Bulk materials are the least suitable for sensor development, since ground and irregular particles are 
difficult to immobilise on transducers, resulting in an uneven distribution of imprinted sites over the 
transducer surface and poor connectivity between polymer binding and the transduction mechanism. 
A compromise between “bulk imprinting” and “surface imprinting” can come from the 
immobilisation of spherical particles, which can be surface-imprinted, onto the transducer surface. In 
particular, nanoparticles would allow for more efficient receptor immobilisation and they can be 
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processed as if they were the plastic equivalent of antibodies. The analogy with antibodies can even 
extend to the use of affinity-based methods for the selection of fractions with the highest binding 
affinity and gel permeation chromatography to select particle fractions with a selected size 
distribution.
37
 There are also methods for the preparation of surface-confined whole protein binding 
sites on microparticle beads, used as supports.
126,134
 An alternative approach is to imprint the protein 
at the interface in mini-emulsion polymerisation.
204,205
 
Other particle-based approaches include the deposition of thin shell layers over core particles, which 
ensure that the imprint sites (which resemble bulk imprints) remain within close proximity to the 
surface.
155,166
 Particle-based approaches to protein imprinting have been reviewed by Tan and Tong.
229
 
The incorporation of particles of larger sizes with transducer surfaces will still involve some of the 
difficulties inherent with bulk polymers, nanoparticles, particularly soluble nanogels, however, could 
be treated as if they were biological molecules to some extent, for which many methods of transducer 
integration are known. 
 
5 Signal transduction 
 
When a protein template binds to its imprinted polymer the resulting physical and chemical changes 
can be exploited to measure the event, i.e. signal transduction. The transducer can either be an 
external component added to the system to monitor binding, for example an electrochemical tag, or 
can be integrated as part of the polymer matrix. Integrated transducer systems allow reagentless 
sensing. Reagentless sensing is a current driver in sensing technology due to the decreased time to 
result, reduced assay complexity and fewer steps associated with generating a signal. Here we 
describe sensor techniques using either polymers prepared on planar surfaces, as shells over 
nanoparticle cores, or synthesised as nanoparticles. Such preparations are favourable for use in 
sensing as the binding element can be efficiently coupled to the transducing element, and there is an 
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adequate number of binding sites exposed on the polymer surface, resulting in improved sensitivity 
and response time. 
A significant advantage of MIPs over biologically-derived affinity agents are their long-term stability, 
relative insensitivity to harsh reagents and the ability to measure multiple “repeated” binding 
reactions. The continuous detection of analytes over prolonged periods and in a reagentless system is 
an obvious application for MIPs and has been exploited to detect the pesticide carbaryl in water ( 
200 binding cycles with good assay stability for at least 4 months) using the native fluorescence of the 
analyte.
230
 We will focus this discussion on signal transduction mechanisms that can be applied to 
reagentless sensing, however where sensitivity is a major issue an external transducer, or competition 
assay (e.g. for ribonuclease A
231
), can be used to amplify the signal, improving the limit of detection.  
Various reviews of MIP signal transduction mechanisms have been published,
232
 however many of 
these methods are for small molecules and depend on specific chemical functionalities for signal 
transduction that are not applicable to general protein analysis. These transduction techniques include; 
electrochemical, fluorescent quenching, IR and Raman spectroscopy. Unless the protein template 
contains an electro-active moiety, metal complex, or is intrinsically fluorescent (aromatic fluorescence 
is not suitable due to strong background and low quantum efficiency), reagentless protein detection 
transduction systems would appear to be limited. These include optical, or acoustic measurement of 
changes in the polymer thickness, refractive index, bulk properties, or swelling upon binding; or 
electrical changes at, or within the polymer upon binding, that can result in: shielding, or re-
organisation of the polymers within the MIP layer, a change in the dielectric constant, or in charge 
distribution at the electrode. 
5.1 Signal transduction using polymers 
Polymers can be either selected, or designed to incorporate the transducing element of the sensor, 
thereby limiting the need for additional sensor components. For many of the electrical and 
electrochemical techniques described, the use of conducting polymers
233
 within the MIP 
polymerization reaction is required. The intrinsic conduction of a polymer is apparent upon oxidation, 
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or reduction „doping‟ of the conjugated backbone. Doping can also change the optical properties of 
the conducting polymer in the UV-vis and NIR regions leading to new applications for optical 
sensing. Such conducting polymers are also influenced by protonation/deprotonation and 
conformational changes in the receptor/sensor layer that alter ion diffusion and therefore conducting 
properties.  
 
Libraries of polymers used for selection and modelling will therefore be biased to include a proportion 
of conducting polymers for electrical/electrochemical sensors.  Conducting polymers that have 
previously been used in the development of imprinted receptors include: polypyrrole, polyaniline and 
benzophenone. The application, use and incorporation of conducting polymers in electrochemical 
sensors has been reviewed.
234
 Energy transfer associated with conducting polymers can also be used 
as the basis for fluorescence-based sensors. Fluorescent mechanisms that have been used in MIP-
based sensors include; photo-induced electronic transfer (PET), replacement of coordinating ligands, 
changes in rigidity, complexation and alteration of quenching efficiency. Unless significant changes 
in fluorescent quenching are observed, the background signal from unbound conducting polymers will 
reduce the sensitivity of the assay, potentially limiting its use for protein analysis. 
 
5.2 Electrical and electrochemical sensors  
Electrochemical techniques relevant to sensing include; voltammetry and amperometry, potentiometry 
and impedometry transduction methods. These techniques have been used in the development of MIP-
based sensors, with the majority of examples involving the detection of small molecule electro-active 
analytes,
235,236
 as opposed to proteins. However notable examples include: an immunosensor-based 
detection of prostate-specific antigen (PSA) through oxidation of Trp and Tyr residues;
237
 a MIP 
sensor for chiral amino acid recognition that could be adapted for proteins
201
  and a potentiometric 
sensor for selective detection of either myoglobin or haemoglobin in complex protein mixtures.
164
 The 
potentiometric sensor displayed protein detection in the low g/ml range and specificity when 
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compared to proteins of similar size and charge. Binding of charged protein to an insulating layer of 
MIP over an electrode alters the surface potential, allowing binding to be measured 
potentiometrically.
164
 The sensor response depends on the isoelectric point of the protein and the pH 
of the sample matrix, however this dependency may be exploited to enhance specificity.      
Capacitance/Impedance sensors can detect analyte binding to imprinted polymers through changes in 
the thickness, and/or dielectric constant of the insulating layer.
238,239
 Polymers used for imprinting in 
capacitive sensors include those prepared from; phenol, MBA, AMPSA and o-phenylenediamine). 
There are limited examples of MIP-based capacitance sensors for protein analytes, however an 
immunosensor for detection of cancer antigen 125 was shown to display good sensitivity, dynamic 
range and the ability to perform repeated measurement using diluted serum samples, when compared 
with SPR and conventional ELISA.
240
 Additional small molecule sensor data and macromolecule 
studies suggest capacitance can be applied for sensitive protein detection. 
Impedance-based spectroscopy has been used to detect a virus binding to MIPs,
241
 and therefore could 
be employed to detect specific proteins associated with organisms, or larger complexes. An 
interdigitated electrode-based capacitor was used to monitor changes in the dielectric properties of the 
MIPs (co-polymer of methacrylic acid and N-vinyl pyrrolidone) occurring upon binding the virus. The 
resulting reusable sensor facilitates continuous, rapid monitoring of complex biological samples, 
albeit with lower detection limits when compared with ELISA. 
Capacitance-based sensors can be prepared inexpensively in bulk using, for example, field-effect 
transistor (FET) technology. Multi-analyte detection can be facilitated by the use of interdigitated 
electrode-based capacitors, making this a flexible technique for protein detection. However other 
techniques, notably optical and electrochemical sensing, offer better sensitivity and specificity as 
various analytes can interfere with the polymer layer.  
 
5.3 Optical and Acoustic Sensors 
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Optical and acoustic sensors that essentially measure changes in the mass of the sensing layer, or 
changes in the refractive index at a surface are both suited to protein analysis. The majority of 
published articles involving the detection of protein- or cell-based analytes use the quartz crystal 
microbalance (QCM), (acoustic) or surface plasmon resonance (SPR), (optical) sensor platforms, due 
to the sensitivity achievable with these techniques compared to other methods. An additional bonus 
arising from using these planar transducers is the relative ease of preparing MIPs on their surfaces. 
Quartz crystal microbalances use a thin disc of quartz, cut at a specific crystal plane, sandwiched 
between a pair of (usually gold) electrodes as the transducer. The piezoelectric crystal oscillates at 
MHz frequencies when an electric field is applied to the crystal. Materials that are acoustically 
coupled to the sensor surface, i.e. due to binding rather than proximity, are detected through changes 
in the oscillation frequency. This offers an advantage over other sensors that measure bulk changes in 
refractive index. In QCM the change in resonance frequency is proportional to the mass of molecules 
bound to the surface. Ligand binding events that alter the conformation or the rigidity of the imprinted 
polymer layer can significantly enhance the resulting signal and can be analysed independently as 
shear modulus, viscosity or density changes. The use of piezoelectric sensors to detect low-molecular 
weight analytes, employing MIPs immobilised to the gold electrodes, has been reviewed.
242
 A MIP-
based QCM sensor has been developed for the detection of anthrax protective antigen.
160
 The sensor 
displayed excellent sensitivity, in the picomolar range, however limited data about specificity and the 
influence of potential interferences was provided, therefore the long term applications of this sensor 
format cannot be assessed. Other examples of protein analytes detected using QCM include native 
trypsin (reported detection limit 100 ng/ml),
243
 micro albumin in clinical samples
244
 and -
lactoglobulin.
172
 QCM provides a flexible technique to measure protein analytes through changes to 
the mass and physicochemical properties of the polymer-sensing surface. The need for acoustic 
coupling to the sensor surface and the relative mass measurement makes this technique less prone to 
interferences. QCM instruments can be adapted for continuous sensing, for prolonged periods as 
highlighted by the on-line detection of pesticides.
245
 
53 
 
The SPR phenomenon requires that the recognition element be coupled to a metallic surface (typically 
silver or gold), or to nanoparticle “island” substrates. The use of SPR in biosensing has been 
reviewed.
246
 In brief, SPR is sensitive to changes in the refractive index of the sensor layer (to a 
distance of around 1000 nm), as a result of analyte binding gives rise to distinct detection modes; 
including changes in intensity and a shift in the SPR angle. Examples of protein analytes detected 
using SPR sensors include lysozyme
203
 and Hepatitis B surface antibody (HBsAb).
194
 HbsAb is a 
biomarker for asymptomatic HBV infection. It was shown that HbsAb can be detected using a 2-
hydroxyethyl methacrylate, N-methacryloyl-L-tyrosine methyl ester-based MIP in diluted serum from 
patients. A significant issue associated with long-term measurements with MIPs in biological 
matrices, is fouling by non-specific protein adsorption, however the authors report that the SPR sensor 
has a significant resistance to this biofouling. Albeit for a limited number of samples, a good 
relationship was observed between the MIP-based SPR assay and a commercially available 
immunoassay.
194
 SPR technology has previously required expensive optical equipment not suited for 
sensing purposes. However recent advances in the availability of low-cost sensing devices have made 
SPR more portable and economically viable for general sensoring requirements.  
Changes in the flexibility and swelling of polymers associated with ligand binding can be exploited to 
measure proteins, albeit with low sensitivity. An example is the detection of BSA, at the level of 1 
mg/ml, through changes in the Bragg shift of imprinted polymer-based photonic crystals.
198,247,248
 
Various optical formats exist to measure ligand-induced changes in swollen polymers and hydrogels, 
however these methods are very sensitive to changes in buffer composition, e.g. pH and ionic 
strength, limiting the potential use of such technology in protein sensing.  
 
5.4 Nanotechnology 
The use of nanoparticles, either prepared on a substrate or in solution, can be applied to MIP-based 
biosensors through adaptation of the transduction routes described above, or through novel 
mechanisms. The techniques and examples given are mainly based on the detection of small 
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molecules, or immunosensor technology, both of which could be applied to the sensing of proteins or 
peptides using MIP technology. Nanoparticles offer many advantages in MIP-based sensing 
including: improved signal sensitivity, increased sensor surface area (making removal of the template 
easier) and novel signal transduction mechanisms.
249,250
 Gold nanoparticle aggregation is routinely 
used in lateral flow devices, which highlights that such technology can be readily adapted to 
inexpensive and disposable platforms for diagnostic applications.  
Compared to planar surfaces, nanostructures can be engineered with high surface to volume ratios, 
increasing the number and ratio of imprinted sites that are accessible for binding, and therefore 
binding capacity of the MIP. The grafting of MIPs to the surface of carbon nanotubes (CNTs),
251,252
 to 
enhance the surface area of electrochemical
253,254
 or electrical transducers has been described. An 
example is the CNT nanoarray, coated with a caffeine-imprinted polypyrrole layer, for which a 15-
fold increase in sensitivity was reported, compared to similarly imprinted planar surfaces. 
251
 An 
electrochemical sensor, using TNT-imprinted Au nanoparticles has been used for the sensitive 
detection of the template, with a reported limit of detection of 46 ppt, (~200 pM).
255
 Silver 
nanoparticles have been used to enhance electron transfer in a MIP-based amperometric sensor for the 
insecticide, dimethoate.
256
 Improvements in the effective receptor surface area could be considered 
more significant for the sensing of large molecules, such as proteins, where mass transfer to the 
surface and limited diffusion into deep polymer layer play an important role in binding kinetics.  
Nanoparticles can be used to increase the effective surface area of a sensor surface. Examples include 
the use of gold colloids, directly immobilised to a polymer surface, in an immuno-capacitance 
sensor
257
 and an electric tunnelling assay,
258
 both for the detection of cholera toxin. The excellent 
sensitivity obtained in these assays and the ability to measure in diluted samples suggests these 
sensors could be adapted for MIP-based sensing. 
MIP nanoparticles can either be prepared directly, for example by microemulsion polymerisation or 
by depositing a shell of polymer over a pre-formed nanoparticle, such as for example quantum dots 
(QDs), or gold colloids. Many of the advantages of using either core-shell nanoparticles, or 
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nanostructured surfaces with MIP‟s will only be apparent if the polymer layer can be prepared 
sufficiently thin and with a regular thickness. A QCM sensor for the detection of the binding of 
imprinted polymer nanoparticles to the peptide melittin, immobilised on the QCM chip has been 
reported.
38
 In this format the MIP-nanoparticle behaved similarly to antibodies using in 
immunoassays, showing the validity of this approach for sensing applications. 
Nanoparticles bearing surface-confined peptide imprints prepared by inverse microemulsion 
polymerisation were similarly shown to bind to peptide targets immobilised on QCM chips.
259
 The 
nanoparticles were prepared with a hydrophobic “tail” in order to confine them at the water-in-oil 
interface and engineer the imprint sites to accept the target peptide in only one orientation. The ability 
to selectively bind from only one terminus of the peptide sequence facilitates protein detection by 
providing more uniform imprints which can target a specific protein chain terminus. The resulting 
MIP nanoparticles bound the target peptide, melittin, with dissociation constants in the range 90-900 
nM. The nanoparticles were prepared from acrylamide and ethylene-bis-acrylamide as functional 
monomer and cross-linker respectively. It would be possible to hydrophobically modify either end of 
a peptide in order to select binding of either the exposed N- or C-terminus of the target protein. It 
would be interesting to see whether peptides, hydrophobically modified at both ends, imprinted in the 
same manner, would allow intra-protein sequences to be targeted, for example surface exposed loops. 
Other methods for the preparation of imprinted nanoparticles for sensor applications have been 
described: polymer
260
 and superparamagnetic particles,
261,262
 Quantum dots
43,176,263
 and 
nanowires.
186,264,265
 The MIP nanoparticles described could be used in various assay formats and 
devices, for example as detection (fluorescent, electrochemical), or capture/separation agents 
(magnetic) in a sandwich complex, or in combination with other binding agents. 
Localized surface plasmon resonance (LSPR) can be obtained from metals, alloys or semiconductors, 
however most examples reported have involved either gold or silver. LSPR nanoparticles display 
scattering spectra whose peak wavelength depends on the particle composition, size, shape, 
orientation and local dielectric environment.
266
 The latter property can be exploited for biosensing 
applications. This has been demonstrated for the binding of conconavalin A to mannose-
56 
 
functionalized nanoparticles.
267
 LSPR has been demonstrated for TNT imprinted gold nanoparticles, 
cross-linked and electropolymerized on a gold surface.
255
 A detection limit of 10 fM was achieved, 
associated with changes in the dielectric properties of the bis-aniline polymer upon the formation of a 
-donor-acceptor complex with the analyte. Nanoparticle islands of gold on a glass substrate were 
employed for enhanced SPR, facilitated by plasmon coupling to gold nanoparticles embedded in a 
cholesterol-imprinted polymer film.
268
 Re-binding of cholesterol led to a shift in the SPR angle. 
Interestingly the binding of structurally similar compounds led to smaller shifts, indicating an 
enhanced discrimination mode. A similar polymer swelling concept, using surface-enhanced Raman 
scattering (SERS) has been reported for adrenaline.
269
 Assays of this type can be limited by slow 
protein diffusion and interferences that alter polymer flexibility/swelling. SERS from Au 
nanoparticles is a sensitive and specific sensor technique for the determination of compounds with 
unique Raman spectra, allowing for their detection within complex mixtures.
270,271
 However the 
enhancement of protein, peptide, or specific amino acids is not as efficient and therefore has not been 
significantly exploited in sensor development. 
 
QDs embedded into polymer films have been reported to detect small molecules such as uracil, 
caffeine
272,273
 and guanosine.
274
 Spectrally distinct QDs with a polymer shell imprinted with creatine, 
lysozyme and albumin were used for sensing in urine.
176
 The QDs were mixed with the template and 
poly(ethylene-co-vinyl alcohol) at different ratios to prepare the mixed QD/MIP nanoparticles. 
Specific binding of the template resulted in quenching of phosphorescence. The unique spectrum of 
each QD allowed for multiplexed analysis. However significant cross-reactivity for creatine with the 
lysozyme and albumin sites was observed. The authors presented data on rebinding, long-term 
stability and a limited comparison with a commercial clinical analyzer. The reported limits of 
detection for albumin and lysozyme, ~ 900 and 200 ng/ml respectively, compares favourably with 
other techniques, however the long-term stability of QDs and the limited fluorescent dynamic range of 
the assay could limit the use of such sensors. 
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A MIP-based sensor has been reported that detected dipicolinic acid (DPA),  a marker for bacterial 
endospores, through analyte-induced fluorescent quenching of gold-silver nanoclusters.
275
 This sensor 
should be more photostable than conventional fluorescent approaches, however the quenching 
mechanism may be specific to DPA, or other small acidic compounds and therefore not applicable to 
protein-based sensing.  
 
Dynamic light scattering
276
 and electrophoresis
107-109
 can be used to detect changes in the physical 
properties of nanoparticles (net charge and size) upon protein binding to an adsorbed receptor. 
Polyacrylamide microparticles imprinted with human haemoglobin were used to specifically detect 
the template using free-zone electrophoresis in a revolving capillary.
109
 
Optical and acoustic techniques still dominate the literature for protein detection using MIPs, based on 
the flexible nature of the techniques. However as advances in MIP development in relation to 
specificity, re-binding and fouling of the polymer surface improve for protein analytes, it is expected 
that more robust/inexpensive techniques, for example conductance, will be required for 
remote/continuous sensing, thereby realising the stability advantages that MIPs confer. We predict 
that initially nanoparticles will have most impact in improving the sensitivity of current transduction 
techniques through enhancements in effective surface area and electron transfer efficiency.  
 
6 Conclusions and recommendations 
The methods and techniques used in molecular imprinting cover a very broad canvas. This is 
especially noticeable when considering methods of imprinting proteins, largely due to the additional 
constraints involved in working with these challenging templates. In our opinion, the most successful 
strategy for imprinting protein targets involves the use of small to medium peptides as the template, 
representing an epitope of the target protein. So far the epitopes chosen have been linear peptides, 
identical in sequence to one of the terminal peptide chains of the target protein; this however is a 
fairly narrow definition of epitope in terms of the regions of proteins recognised by antibodies. In this 
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case more diverse regions of the protein can be the target for antibody binding, whether strategies for 
designing epitope templates, that can be used to imprint recognition properties for surface regions or 
loops of the target, can ever be successfully devised remains to be seen. The problems of entrapment 
and covalent immobilisation of whole proteins suggests that only strategies aimed at surface 
imprinting, at interfaces or by stamping/printing approaches, stand any chance of competing with 
those based on epitope imprinting. As far as polymer systems are involved, soft hydrogels are 
probably not recommended over more rigid systems for use in sensor applications. Nano-structured 
materials and thin films are important formats for sensing applications, in fact MIP nanoparticles can 
be considered as direct replacements for antibodies, and this is expected to be a growing trend since 
they have been demonstrated to act as such in vivo, neutralising the toxic effect of a component of bee 
venom in mice.
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Selection of monomer is important, and computational and combinatorial methods can help. Clearly 
there are cases where a small amount of ionisable or ionised monomer aids in selectivity and 
specificity of recognition, however too much has a detrimental effect. The majority of functional 
monomer should however be neutral, with acrylamide being the clear favourite, imparting recognition 
properties for a wide range of peptide and protein templates. For the sensing platform, a reagentless 
system would be preferable, although a sensing system for proteins will, by necessity, involve some 
form of liquid handling. In transduction, SPR and QCM-based sensors and their allied techniques are 
attractive, as a number of instruments are readily available for use with easily modified sensor chips. 
For electroactive proteins, electrochemical detection would be possible. Such sensors can be sensitive 
and compact, however very few proteins are likely to be redox active in the manner required for 
detection. Other electrical properties, e.g. capacitance or impedance, can be used and may provide the 
required sensitivity.  
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